Ghai Lu
Internal Medicine · Bedford, OHNPI 1588763429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,399 and has fallen 71.1% since, to $404 in 2022.
Across 195 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$338
- GSK$323
- Amgen$306
- AbbVie$234
- Novo Nordisk$220
- Johnson & Johnson$218
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,99799%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $338 |
| GSK | 26 | $323 |
| Amgen | 19 | $306 |
| AbbVie(2 entities) | 14 | $234 |
| Novo Nordisk | 17 | $220 |
| Johnson & Johnson | 17 | $218 |
| Boehringer Ingelheim | 11 | $197 |
| Sanofi-aventis U.S. LLC | 9 | $160 |
| Amarin Pharma, Inc. | 11 | $158 |
| Sunovion Pharmaceuticals Inc. | 9 | $153 |
| Arbor Pharmaceuticals, Inc. | 7 | $141 |
| Lilly USA, LLC | 8 | $126 |
| Merck | 4 | $69 |
| Bayer | 2 | $45 |
| Novartis | 3 | $40 |
| Pfizer | 3 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Medtronic | 1 | $20 |
| Abbott | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
| Circassia Inc. | 1 | $11 |
How this compares
$3,014 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Bedford
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.